Invention Grant
- Patent Title: Targets of Acinetobacter Baumannii
-
Application No.: US15896761Application Date: 2018-02-14
-
Publication No.: US10398767B2Publication Date: 2019-09-03
- Inventor: Simon Urwyler , Markus Haake , Michael Rudolf
- Applicant: Aridis Pharmaceuticals Inc.
- Agency: BCO Patent
- Agent Gary Baker
- Priority: EP11191320 20111130
- Main IPC: A61K39/104
- IPC: A61K39/104 ; C07K14/21 ; C07K14/22 ; C07K16/12 ; A61K39/00
Abstract:
The present invention provides antigenic polypeptides expressed during an infection by a pathogenic organism, such as Acinetobacter and compositions comprising these polypeptides. The invention further provides compositions for use in treating, preventing or detecting a bacterial infection, in particular vaccine compositions using the antigenic polypeptides. The invention further provides antibodies directed to said antigenic polypeptides.
Public/Granted literature
- US20180193445A1 NOVEL TARGETS OF ACINETOBACTER BAUMANNII Public/Granted day:2018-07-12
Information query
